Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07755761
Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomized Controlled TrialBenha UniversityRecruitingNot Applicable
NCT07755761Recruiting
Not Applicable
Innovative Tube Trabeculectomy for Advanced and Refractory Glaucoma: A Randomize...Benha University
NCT07754383
Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With Heart-Kidney Non-interaction SyndromeFohow Pharmaceutical GroupNot Yet RecruitingEarly Phase 1
NCT07754383Not Yet Recruiting
Early Phase 1
Qing-Xin-Jiao-Tai Decoction for Insomnia Comorbid With Obesity Presenting With H...Fohow Pharmaceutical Grou...
NCT07755410
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)Alkermes, Inc.RecruitingPhase 2
NCT07755410Recruiting
Phase 2
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Ad...Alkermes, Inc.
NCT07754253
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Locally Delivered Nanotherapeutic in the Treatment of Stage II PeriodontitisMansoura UniversityRecruitingPhase 1
NCT07754253Recruiting
Phase 1
Effectiveness of Epigallocatechin-3-Gallate (Green Tea Extract) as Adjunctive Lo...Mansoura University
NCT07756333
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologiesyoussef alaaCompletedNot Applicable
NCT07756333Completed
Not Applicable
Evaluation of Composite Veneers Fabricated by 3D Printing and Milling Technologi...youssef alaa
NCT07756593
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate CancerDendreonNot Yet RecruitingPhase 1
NCT07756593Not Yet Recruiting
Phase 1
Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Mo...Dendreon
NCT07754357
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block in AV Fistula Surgery.Aswan University HospitalEnrolling By InvitationNot Applicable
NCT07754357Enrolling By Invitation
Not Applicable
Ultrasound-Guided T2 Erector Spinae Plane Block Versus Intercostobrachial Block...Aswan University Hospital
NCT07755046
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang ChangCompletedNot Applicable
NCT07755046Completed
Not Applicable
Repetitive Transcranial Magnetic Stimulation for Alcohol Use DisorderTing-Gang Chang
NCT07756554
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospital AdmissionAmager HospitalRecruitingNot Applicable
NCT07756554Recruiting
Not Applicable
Clinical Assessment and Treatment in the Nursing Home as an Alternative to Hospi...Amager Hospital
NCT07755059
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated CirrhosisMassachusetts General HospitalNot Yet RecruitingNot Applicable
NCT07755059Not Yet Recruiting
Not Applicable
Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Asci...Massachusetts General Hos...
NCT07753993
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.AstraZenecaNot Yet RecruitingPhase 3
NCT07753993Not Yet Recruiting
Phase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult...AstraZeneca
NCT07754708
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences UniversityNot Yet RecruitingNot Applicable
NCT07754708Not Yet Recruiting
Not Applicable
The Effect of Carpal Tunnel Syndrome Phenotyping on Response to TreatmentKutahya Health Sciences U...
NCT07755124
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled TrialWest China HospitalNot Yet RecruitingPhase 1
NCT07755124Not Yet Recruiting
Phase 1
Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Tre...West China Hospital
NCT07754097
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National University HospitalRecruiting
NCT07754097Recruiting
—
Self-Management Data and Disease Progression in Chronic Kidney DiseaseChungnam National Univers...
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07755384
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Tract at High Altitude (Zaduo County)Jilin UniversityRecruiting
NCT07755384Recruiting
—
A Prospective Cohort Study on Endoscopic Features of Upper Gastrointestinal Trac...Jilin University
NCT07755995
Latin Dance and Psychological Health in Primary School ChildrenXu ShuishuiNot Yet RecruitingNot Applicable
NCT07755995Not Yet Recruiting
Not Applicable
Latin Dance and Psychological Health in Primary School ChildrenXu Shuishui
NCT07754344
Dural Medical Adhesive for Watertight Sealing in Dural RepairMedprin Regenerative Medical Technologies Co., Ltd.CompletedPhase 3
NCT07754344Completed
Phase 3
Dural Medical Adhesive for Watertight Sealing in Dural RepairMedprin Regenerative Medi...
NCT07755696
Robotic Single Port Combined Umbilical and Inguinal Hernia RepairAlgemeen Ziekenhuis Maria MiddelaresRecruitingNot Applicable
NCT07755696Recruiting
Not Applicable
Robotic Single Port Combined Umbilical and Inguinal Hernia RepairAlgemeen Ziekenhuis Maria...
NCT07755163
Screening Cancer Readiness Through Education and Empowerment for Newcomer WomenErzincan Binali Yildirim UniversitesiNot Yet RecruitingNot Applicable
NCT07755163Not Yet Recruiting
Not Applicable
Screening Cancer Readiness Through Education and Empowerment for Newcomer WomenErzincan Binali Yildirim...
Result Breakdown
Recruiting8 (40%)
Not yet recruiting8 (40%)
Completed3 (15%)
Enrolling by invitation1 (5%)
not_applicable10 (50%)
Phase 13 (15%)
Not Specified3 (15%)
Phase 32 (10%)
Early Phase 11 (5%)
Phase 21 (5%)